HARBOURVEST PARTNERS LLC - Q1 2023 holdings

$297 Million is the total value of HARBOURVEST PARTNERS LLC's 63 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 24.6% .

 Value Shares↓ Weighting
 N-Able, Inc.$49,098,720
+28.4%
3,719,6000.0%16.54%
+29.1%
 Toast, Inc.$40,521,085
-1.6%
2,282,8780.0%13.65%
-1.0%
W  Wayfair Inc.$36,473,407
+4.4%
1,062,1260.0%12.28%
+5.0%
NewSolarwinds Corp.$31,988,5603,719,600
+100.0%
10.77%
MNDY  monday.com Ltd.$25,973,791
+17.0%
181,9530.0%8.75%
+17.7%
BuyOmega Therapeutics, Inc.$21,178,023
+40.1%
3,512,110
+32.7%
7.13%
+40.9%
NewHesai Groupsponsored ads$9,375,764606,061
+100.0%
3.16%
YMM  Full Truck Alliance Co. Ltd.adr$7,287,184
-4.9%
957,5800.0%2.45%
-4.4%
NewHashiCorp, Inc.$6,699,648228,735
+100.0%
2.26%
NewHammerhead Energy Inc.$5,559,552716,899
+100.0%
1.87%
RLAY  Relay Therapeutics, Inc.$4,881,741
+10.2%
296,4020.0%1.64%
+10.9%
IAS  Integral Ad Science, Inc.$4,356,602
+62.3%
305,2980.0%1.47%
+63.2%
LC  LendingClub Corp.$3,701,902
-18.1%
513,4400.0%1.25%
-17.6%
 Sonder Holdings, Inc.$3,408,678
-38.9%
4,502,2830.0%1.15%
-38.6%
BE  Bloom Energy Corporation$3,232,626
+4.2%
162,1990.0%1.09%
+4.8%
AXLA  Axcella Health, Inc.$2,979,806
+46.3%
6,207,9290.0%1.00%
+47.2%
NewTim Hortons Chinaordinary shares$2,429,493596,927
+100.0%
0.82%
NARI  Inari Medical$2,379,460
-2.9%
38,5400.0%0.80%
-2.3%
SPOT  Spotify Technology S.A.$2,240,273
+69.2%
16,7660.0%0.76%
+70.4%
FTCH  Farfetch Ltd.ordinary shares cla$2,173,736
+3.8%
442,7160.0%0.73%
+4.4%
COUR BuyCoursera, Inc.$1,983,433
+58.0%
172,173
+62.3%
0.67%
+59.0%
 Amplitude Inc.$1,903,544
+3.0%
153,0180.0%0.64%
+3.6%
ACVA  ACV Auctions, Inc.$1,898,829
+57.2%
147,0820.0%0.64%
+58.4%
DOCN  Digital Ocean, Inc.$1,731,706
+53.8%
44,2100.0%0.58%
+54.6%
ZUO  Zuora, Inc.$1,619,273
+55.3%
163,8940.0%0.54%
+56.2%
DOCS  Doximity, Inc.$1,612,654
-3.5%
49,8040.0%0.54%
-3.0%
OLO  Olo, Inc.$1,536,552
+30.6%
188,3030.0%0.52%
+31.5%
SUMO  Sumo Logic, Inc.$1,530,900
+47.9%
127,7880.0%0.52%
+48.7%
FROG  Jfrog Ltd.$1,162,458
-7.6%
59,0080.0%0.39%
-7.1%
PATH  UiPath, Inc.$1,118,572
+38.2%
63,7000.0%0.38%
+39.1%
U  Unity Software$1,109,253
+13.5%
34,1940.0%0.37%
+14.4%
PGNY  Progyny, Inc.$1,024,146
+3.1%
31,8850.0%0.34%
+3.6%
TWLO  Twilio, Inc.$970,932
+36.1%
14,5720.0%0.33%
+36.8%
ONTF  ON24, Inc.$956,680
+1.5%
109,2100.0%0.32%
+1.9%
ZI  Zoom Information, Inc$956,104
-17.9%
38,6930.0%0.32%
-17.4%
BHG  Bright Health Group, Inc.$929,163
-66.1%
4,217,7150.0%0.31%
-65.9%
EB  Eventbrite, Inc.$876,567
+46.4%
102,1640.0%0.30%
+46.8%
HNST  The Honest Company Inc.$856,132
-40.2%
475,6290.0%0.29%
-40.0%
DIBS  1stdibs.com, Inc.$791,999
-21.9%
199,4960.0%0.27%
-21.2%
SGTX  Sigilon Therapeutics, Inc.$688,962
+165.7%
740,7400.0%0.23%
+166.7%
IBRX  ImmunityBio, Inc.$610,990
-64.1%
335,7090.0%0.21%
-63.9%
PINS  Pinterest, Inc.$581,124
+12.3%
21,3100.0%0.20%
+13.3%
 SmartRent.com$561,811
+4.9%
220,3180.0%0.19%
+5.6%
EVLO  Evelo Biosciences, Inc.$553,575
-88.8%
3,063,5050.0%0.19%
-88.7%
 Robinhood Markets Inc.$492,151
+19.3%
50,6850.0%0.17%
+20.3%
VYGR NewVoyager Therapeutics, Inc.$476,29361,776
+100.0%
0.16%
CPNG  Coupang Inc.$429,344
+8.8%
26,8340.0%0.14%
+9.8%
MCRB  Seres Therapeutics, Inc.$279,888
+1.2%
49,3630.0%0.09%
+1.1%
PACB  Pacific Biosciences of California, Inc.$271,945
+41.6%
23,4840.0%0.09%
+43.8%
AFRM  Affirm, Inc.$261,577
+16.5%
23,2100.0%0.09%
+17.3%
QS  QuantumScape Corporation$236,819
+44.3%
28,9510.0%0.08%
+45.5%
DASH  DoorDash, Inc.$159,218
+30.2%
2,5050.0%0.05%
+31.7%
 Rallybio Holdings, LLC$124,918
-13.1%
21,8770.0%0.04%
-12.5%
RPTX  Repare Therapeutics, Inc.$120,796
-33.1%
12,2760.0%0.04%
-31.7%
IPSC  Century Therapeutics, Inc.$100,692
-32.4%
29,0180.0%0.03%
-32.0%
RYTM NewRhythm Pharmaceuticals, Inc.$100,6005,639
+100.0%
0.03%
OPEN  Opendoor Technologies Inc.$82,204
+51.7%
46,7070.0%0.03%
+55.6%
ASTR  Astra Space, Inc.$79,333
-2.1%
186,6660.0%0.03%0.0%
LOV  Spark Networks SEsponsored adr$69,833
+3.1%
104,2280.0%0.02%
+4.3%
PMVP  PMV Pharmaceuticals$55,012
-45.2%
11,5330.0%0.02%
-44.1%
 GreenLight Biosciences, Inc.$21,097
-63.4%
48,8350.0%0.01%
-63.2%
ALGS  Aligos Therapeutics, Inc.$16,416
-8.3%
18,7830.0%0.01%0.0%
NXTC  NextCure, Inc.$14,865
+5.0%
10,0440.0%0.01%0.0%
RUBY ExitRubius Therapeutics, Inc.$0-986,878
-100.0%
-0.06%
DCT ExitDuck Creek Technologies, Inc.$0-14,508
-100.0%
-0.06%
LZ ExitLegalZoom.com, Inc.$0-45,767
-100.0%
-0.12%
ExitRocket Lab USA, Inc.$0-95,416
-100.0%
-0.12%
PCOR ExitProcore Technologies, Inc.$0-18,414
-100.0%
-0.29%
SQSP ExitSquarespace, Inc.class a$0-138,839
-100.0%
-1.03%
PAYO ExitPayoneer, Inc.$0-717,416
-100.0%
-1.31%
ExitAvidXchange Holdings, Inc.$0-3,387,792
-100.0%
-11.28%
SWI ExitSolarwinds Corp.$0-3,719,600
-100.0%
-11.66%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wayfair, Inc.25Q3 202383.5%
Trevena, Inc.25Q4 20211.2%
Finjan Holdings, Inc.23Q2 202018.5%
Zuora, Inc.21Q3 20233.4%
Evelo Biosciences, Inc.20Q1 202326.3%
CytomX Therpeutics, Inc.19Q4 20212.3%
LendingClub Corp.18Q3 201911.9%
Rubius Therapeutics, Inc.18Q4 202221.4%
Solarwinds Corp.17Q4 202260.4%
Axcella Health, Inc.17Q2 20236.7%

View HARBOURVEST PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HARBOURVEST PARTNERS LLC Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SolarWinds CorpFebruary 14, 20223,719,6002.3%
N-able, Inc.December 20, 20213,719,6002.1%
OncoMed Pharmaceuticals IncFebruary 14, 20191,901,1064.9%
Wayfair Inc.February 16, 20162,115,2964.6%
ENVIVIO INCFebruary 13, 20133,639,93913.5%
NETWORK ENGINES INCSold outFebruary 13, 201300.0%
VOCALTEC COMMUNICATIONS LTDAugust 06, 2010243,6892.1%
CERAGON NETWORKS LTDSold outJuly 26, 200700.0%
VISTAPRINT LTDSold outFebruary 14, 200700.0%
VOCALTEC COMMUNICATIONS LTDMay 26, 20061,218,44424.4%

View HARBOURVEST PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
40-APP2024-04-24
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR/A2022-05-26
13F-HR2022-05-13

View HARBOURVEST PARTNERS LLC's complete filings history.

Compare quarters

Export HARBOURVEST PARTNERS LLC's holdings